Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Azenta (AZTA) Cash & Equivalents (2016 - 2025)

Azenta (AZTA) has disclosed Cash & Equivalents for 16 consecutive years, with $336.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents changed N/A to $336.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $336.6 million, a N/A change, with the full-year FY2025 number at $279.8 million, changed 0.09% from a year prior.
  • Cash & Equivalents was $336.6 million for Q4 2025 at Azenta, up from $279.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.9 billion in Q1 2022 to a low of $215.2 million in Q4 2021.
  • A 5-year average of $591.1 million and a median of $353.5 million in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: surged 504.89% in 2022, then plummeted 65.53% in 2023.
  • Azenta's Cash & Equivalents stood at $215.2 million in 2021, then skyrocketed by 182.71% to $608.3 million in 2022, then rose by 15.55% to $702.9 million in 2023, then crashed by 60.16% to $280.0 million in 2024, then rose by 20.21% to $336.6 million in 2025.
  • Per Business Quant, the three most recent readings for AZTA's Cash & Equivalents are $336.6 million (Q4 2025), $279.8 million (Q3 2025), and $280.0 million (Q3 2024).